Analysts Set GE HealthCare Technologies Inc. (NASDAQ:GEHC) PT at $92.50

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHCGet Free Report) have been assigned a consensus recommendation of “Hold” from the fourteen ratings firms that are covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $92.50.

GEHC has been the topic of several recent analyst reports. Jefferies Financial Group upped their price target on GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Thursday, December 11th. Citigroup upped their target price on GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a research report on Thursday, December 11th. Stifel Nicolaus raised their price target on GE HealthCare Technologies from $95.00 to $98.00 and gave the company a “buy” rating in a research report on Wednesday, February 4th. The Goldman Sachs Group reiterated a “buy” rating and set a $98.00 target price on shares of GE HealthCare Technologies in a research note on Friday, January 9th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th.

View Our Latest Analysis on GEHC

Institutional Trading of GE HealthCare Technologies

A number of hedge funds have recently modified their holdings of GEHC. Laurel Wealth Advisors LLC bought a new stake in GE HealthCare Technologies during the fourth quarter worth $26,000. Optima Capital LLC bought a new stake in GE HealthCare Technologies in the fourth quarter valued at approximately $27,000. Godfrey Financial Associates Inc. acquired a new stake in shares of GE HealthCare Technologies during the fourth quarter worth $27,000. Montag A & Associates Inc. grew its holdings in GE HealthCare Technologies by 105.4% during the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after acquiring an additional 175 shares during the period. Finally, Transamerica Financial Advisors LLC increased its holdings in GE HealthCare Technologies by 331.6% in the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock worth $28,000 after purchasing an additional 262 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $80.34 on Friday. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13. GE HealthCare Technologies has a 12-month low of $57.65 and a 12-month high of $93.26. The business’s fifty day moving average price is $82.44 and its 200 day moving average price is $77.62. The stock has a market capitalization of $36.61 billion, a PE ratio of 17.62, a price-to-earnings-growth ratio of 1.73 and a beta of 1.08.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last posted its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.40 by $0.04. The company had revenue of $5.70 billion for the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The firm’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same period last year, the business posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities research analysts forecast that GE HealthCare Technologies will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s payout ratio is 3.07%.

GE HealthCare Technologies Company Profile

(Get Free Report)

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

Read More

Analyst Recommendations for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.